Skip to main content

Table 2 The clinicopathologic characteristics of the patients of survival group and dead group

From: Is hysterectomy beneficial in radical cystectomy for female patient with urothelial carcinoma of bladder? A retrospective analysis of consecutive 112 cases from a single institution

 

Survival (n = 71)

Dead (n = 41)

p

Age (yr)

65.5 ± 11.5

70.8 ± 9.2

0.014a

BMI (kg/m2)

23.7 (21.4–26.6)

23.4 (20.8–26.2)

0.570b

ORC

50 (70.4%)

34 (82.9%)

0.141c

LRC

21 (29.6%)

7 (17.1%)

 

Location of the tumor

  

0.107c

 Posterior wall or trigone

47 (66.2%)

33 (80.5%)

 

 Other location

24 (33.8%)

8 (19.5%)

 

Pathologic stage

  

0.014c

 Ta and Tis and T1

21 (29.6%)

7 (17.1%)

 

 T2

30 (42.3%)

11 (26.8%)

 

 T3 and T4

20 (28.2%)

23 (56.1%)

 

Pathologic nodal stage

  

0.043c

 N0

65 (91.5%)

32 (78.0%)

 

 N+

6 (8.5%)

9 (22.0%)

 

Negative margin

69 (97.2%)

38 (92.7%)

0.159c

Positive margin

2 (2.8%)

3 (7.3%)

 

No neoadjuvant/adjuvant chemotherapy

66 (93.0%)

29 (72.5%)

0.004c

Neoadjuvant/adjuvant chemotherapy

5 (7.0%)

11 (26.8%)

 
  1. BMI Body Mass Index, ASA American Society of Anesthesiologists, ORC open radical cystectomy, LRC laparoscopic radical cystectomy, aIndependent-Samples T test, bMann-Whitney U test, cχ2 test (or Fisher’s exact test)